(E)-4-(3-(3-Cyanophenyl)acryloyl)-N-cyclopropylbenzenesulfonamide

ID: ALA4560739

PubChem CID: 155558593

Max Phase: Preclinical

Molecular Formula: C19H16N2O3S

Molecular Weight: 352.42

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  N#Cc1cccc(/C=C/C(=O)c2ccc(S(=O)(=O)NC3CC3)cc2)c1

Standard InChI:  InChI=1S/C19H16N2O3S/c20-13-15-3-1-2-14(12-15)4-11-19(22)16-5-9-18(10-6-16)25(23,24)21-17-7-8-17/h1-6,9-12,17,21H,7-8H2/b11-4+

Standard InChI Key:  ORFZFCXMPHRQOS-NYYWCZLTSA-N

Molfile:  

 
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   38.8042  -20.4711    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.2169  -19.7653    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   38.3994  -19.7607    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.9254  -20.1739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.9242  -20.9934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6323  -21.4024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3420  -20.9929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.3391  -20.1703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.6305  -19.7650    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0503  -21.4004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.0516  -22.2176    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.7574  -20.9907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.7561  -20.1735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4632  -19.7638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1691  -20.1723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.8757  -19.7633    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.8749  -18.9452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1615  -18.5379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.4579  -18.9493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.2174  -18.9482    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   44.1546  -17.7209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.1504  -16.9037    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.5099  -18.5392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0996  -17.8362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6906  -18.5436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  4  1  0
  7 10  1  0
 10 11  2  0
 10 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 14  1  0
  4  2  1  0
  2 20  1  0
 21 22  3  0
 18 21  1  0
 20 23  1  0
 24 23  1  0
 25 24  1  0
 23 25  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4560739

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 352.42

Molecular Weight (Monoisotopic): 352.0882

AlogP: 2.90

#Rotatable Bonds: 6

Polar Surface Area: 87.03

Molecular Species: NEUTRAL

HBA: 4

HBD: 1

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 9.86

CX Basic pKa: ┄

CX LogP: 3.04

CX LogD: 3.04

Aromatic Rings: 2

Heavy Atoms: 25

QED Weighted: 0.64

Np Likeness Score: -1.37

References

1. Yang S, Shergalis A, Lu D, Kyani A, Liu Z, Ljungman M, Neamati N..  (2019)  Design, Synthesis, and Biological Evaluation of Novel Allosteric Protein Disulfide Isomerase Inhibitors.,  62  (7): [PMID:30759340] [10.1021/acs.jmedchem.8b01951]

Source

Source(1):

• Scientific Literature